# Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome

> **NCT01728922** · PHASE1,PHASE2 · COMPLETED · sponsor: **University College Dublin** · enrollment: 64 (actual)

## Conditions studied

- Clinically Isolated Syndrome
- Multiple Sclerosis

## Interventions

- **DIETARY_SUPPLEMENT:** 5000IU vitamin D
- **DIETARY_SUPPLEMENT:** 10000IU vitamin D
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01728922
- **Lead sponsor:** University College Dublin
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-06
- **Primary completion:** 2015-06-05
- **Final completion:** 2016-06-05
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2017-05-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01728922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01728922, "Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01728922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
